McIlhany M P, Johns L M, Leipzig T, Patronas N J, Brown F D, Mullan S F
J Neurosurg. 1983 Mar;58(3):356-61. doi: 10.3171/jns.1983.58.3.0356.
Partially purified protein from washed and artificially hemolyzed erythrocytes, known to cause significant contractions of isolated canine cerebral vessels in vitro, was injected into the cisterna magna of intact anesthetized dogs. Cerebral blood flow, measured by the xenon-133 washout technique, decreased from a control value of 49.5 +/- 1.17 ml/100 gm/min to an experimental value of 34.1 +/- 1.65 ml/100 gm/min at 2 hours. Cerebral vascular resistance rose from a control value of 2.05 +/- 0.17 PRU (peripheral resistance units) to an experimental value of 2.91 +/- 0.25 PRU at 2 hours. Mean arterial blood pressure, heart rate, intracranial pressure, and cerebral perfusion pressure remained stable. Cardiac output also fell significantly (in 2-hour control animals it was 2.89 +/- 0.37 liter/min, and in 2-hour experimental animals 1.43 +/- 0.13 liter/min) and peripheral vascular resistance rose. These changes were evident by 10 minutes after the cisternal injection of the hemolysate protein, and remained for the duration of the 2-hour monitoring period. Serial vertebrobasilar angiograms demonstrated marked narrowing of the intracranial basilar artery when compared to control values. The narrowing persisted for several days in most animals, and tended to increase with time. Relaxation occurred by the 10th through the 14th day. The authors conclude that this experimental preparation may be a useful model for both in vitro and in vivo investigation of chronic cerebral vasospasm.
从经洗涤和人工溶血的红细胞中提取的部分纯化蛋白,已知其在体外可引起离体犬脑血管显著收缩,将其注入完整麻醉犬的小脑延髓池。采用氙 - 133洗脱技术测量脑血流量,2小时时,脑血流量从对照值49.5±1.17 ml/100 gm/min降至实验值34.1±1.65 ml/100 gm/min。脑血管阻力在2小时时从对照值2.05±0.17 PRU(外周阻力单位)升至实验值2.91±0.25 PRU。平均动脉血压、心率、颅内压和脑灌注压保持稳定。心输出量也显著下降(2小时对照动物的心输出量为2.89±0.37升/分钟,2小时实验动物的心输出量为1.43±0.13升/分钟),外周血管阻力升高。这些变化在小脑延髓池注射溶血产物蛋白10分钟后明显,并在2小时监测期内持续存在。系列椎基底动脉血管造影显示,与对照值相比,颅内基底动脉明显变窄。在大多数动物中,这种变窄持续数天,并随时间趋于加重。第10天至第14天出现血管舒张。作者得出结论,该实验制剂可能是慢性脑血管痉挛体外和体内研究的有用模型。